Financials Rayence Co., Ltd.

Equities

A228850

KR7228850004

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 03:30:00 16/05/2024 am IST 5-day change 1st Jan Change
8,510 KRW +0.35% Intraday chart for Rayence Co., Ltd. -0.82% -8.98%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,08,508 1,72,314 1,92,771 1,73,101 1,47,136 1,33,917 - -
Enterprise Value (EV) 2 124.4 86.85 94.08 49.22 147.1 -3.933 -19.03 -35.13
P/E ratio 14.2 x -89.8 x 13.3 x 7.77 x 7.5 x 8.18 x 6.54 x 6.02 x
Yield 0.75% 0.91% 0.82% 0.91% - 1.18% 1.18% 1.18%
Capitalization / Revenue 1.65 x 1.7 x 1.43 x 1.18 x 1.03 x 0.93 x 0.86 x 0.79 x
EV / Revenue 0.99 x 0.86 x 0.7 x 0.33 x 1.03 x -0.03 x -0.12 x -0.21 x
EV / EBITDA 4.16 x 5.56 x 3.09 x 1.64 x 6.31 x -0.19 x -0.76 x -1.3 x
EV / FCF 54.8 x 4.18 x 4.94 x 3.35 x - 1.71 x -0.97 x -1.73 x
FCF Yield 1.82% 23.9% 20.2% 29.9% - 58.5% -104% -57.8%
Price to Book 1.07 x 0.92 x 0.96 x 0.77 x - 0.57 x 0.53 x 0.49 x
Nbr of stocks (in thousands) 15,736 15,736 15,736 15,736 15,736 15,736 - -
Reference price 3 13,250 10,950 12,250 11,000 9,350 8,510 8,510 8,510
Announcement Date 26/02/20 28/01/21 27/01/22 15/02/23 19/02/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 126.2 101.5 134.5 147.2 143 143.2 155.9 170.2
EBITDA 1 29.87 15.62 30.48 29.96 23.33 20.95 25.1 27.05
EBIT 1 22.84 8.436 24.75 26.14 19.75 16.95 21 22.85
Operating Margin 18.1% 8.31% 18.4% 17.76% 13.82% 11.83% 13.47% 13.43%
Earnings before Tax (EBT) 1 21.64 -2.018 20.7 26.04 23.63 21.5 26.55 28.95
Net income 1 15.3 -1.916 13.96 22.63 19.6 17.15 21.5 23.35
Net margin 12.13% -1.89% 10.38% 15.38% 13.71% 11.97% 13.79% 13.72%
EPS 2 933.0 -122.0 919.0 1,416 1,246 1,040 1,300 1,414
Free Cash Flow 3 2,268 20,763 19,029 14,696 - -2,300 19,700 20,300
FCF margin 1,797.81% 20,450.99% 14,145.54% 9,986.37% - -1,605.58% 12,636.31% 11,930.65%
FCF Conversion (EBITDA) 7,594.49% 1,32,914.83% 62,438.83% 49,054.17% - - 78,486.06% 75,046.21%
FCF Conversion (Net income) 14,824.14% - 1,36,261.3% 64,935.12% - - 91,627.91% 86,937.9%
Dividend per Share 2 100.0 100.0 100.0 100.0 - 100.0 100.0 100.0
Announcement Date 26/02/20 28/01/21 27/01/22 15/02/23 19/02/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q2 2024 Q3 2024 Q4
Net sales 1 33.06 33.33 36.11 37.63 39.15 34.28 37.59 37.74 36.13 31.53 37.8 37.1 32.6
EBITDA - - - - - - - - - - - - -
EBIT 1 6.232 5.416 6.126 7.779 7.912 3.766 5.691 6.545 4.737 2.78 5.45 4.85 2.55
Operating Margin 18.85% 16.25% 16.96% 20.67% 20.21% 10.99% 15.14% 17.34% 13.11% 8.82% 14.42% 13.07% 7.82%
Earnings before Tax (EBT) 1 4.974 4.364 6.573 7.715 10.14 1.057 4.67 7.154 8.872 2.935 6.8 6.8 2.8
Net income 1 3.476 2.997 5.114 6.158 6.808 4.196 2.997 6.201 7.951 2.451 5.6 5.6 2.3
Net margin 10.51% 8.99% 14.16% 16.37% 17.39% 12.24% 7.97% 16.43% 22.01% 7.77% 14.81% 15.09% 7.06%
EPS 2 - 222.0 - - - - 190.0 - - 156.0 1,373 - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 09/11/21 27/01/22 03/05/22 08/08/22 08/11/22 15/02/23 15/05/23 08/08/23 08/11/23 19/02/24 - - -
1KRW in Billions2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 84.1 85.5 98.7 124 - 138 153 169
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 2 2,268 20,763 19,029 14,696 - -2,300 19,700 20,300
ROE (net income / shareholders' equity) 8.14% -2.87% 7.22% 10.6% - 7.05% 8.4% 8.4%
ROA (Net income/ Total Assets) 6.54% -2.39% 6.2% 8.98% - 5.8% 6.1% 6.3%
Assets 1 234.1 80.14 225.3 251.9 - 295.7 352.5 370.6
Book Value Per Share 3 12,347 11,957 12,746 14,282 - 14,972 16,175 17,492
Cash Flow per Share 3 1,748 1,478 1,331 1,055 - 1,249 1,319 1,443
Capex 1 7.18 2.49 1.91 1.91 - 1.5 2.3 1.65
Capex / Sales 5.69% 2.45% 1.42% 1.3% - 1.05% 1.48% 0.97%
Announcement Date 26/02/20 28/01/21 27/01/22 15/02/23 19/02/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8,510 KRW
Average target price
11,500 KRW
Spread / Average Target
+35.14%
Consensus
  1. Stock Market
  2. Equities
  3. A228850 Stock
  4. Financials Rayence Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW